000 | 01964 a2200577 4500 | ||
---|---|---|---|
005 | 20250517164834.0 | ||
264 | 0 | _c20180612 | |
008 | 201806s 0 0 eng d | ||
022 | _a1873-7064 | ||
024 | 7 |
_a10.1016/j.neuropharm.2017.07.022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSałat, Kinga | |
245 | 0 | 0 |
_aAntinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT _h[electronic resource] |
260 |
_bNeuropharmacology _cOct 2017 |
||
300 |
_a181-188 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnalgesics _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtoxicity |
650 | 0 | 4 |
_aCyclohexanes _xpharmacology |
650 | 0 | 4 |
_aDiabetic Neuropathies _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFormaldehyde |
650 | 0 | 4 | _aHot Temperature |
650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNeuralgia _xdrug therapy |
650 | 0 | 4 |
_aNociceptive Pain _xdrug therapy |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xtoxicity |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT1A _xmetabolism |
650 | 0 | 4 |
_aSerotonin 5-HT1 Receptor Agonists _xpharmacology |
650 | 0 | 4 |
_aSerotonin 5-HT1 Receptor Antagonists _xpharmacology |
650 | 0 | 4 | _aStreptozocin |
650 | 0 | 4 | _aTouch |
700 | 1 | _aKołaczkowski, Marcin | |
700 | 1 | _aFurgała, Anna | |
700 | 1 | _aRojek, Adriana | |
700 | 1 | _aŚniecikowska, Joanna | |
700 | 1 | _aVarney, Mark A | |
700 | 1 | _aNewman-Tancredi, Adrian | |
773 | 0 |
_tNeuropharmacology _gvol. 125 _gp. 181-188 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2017.07.022 _zAvailable from publisher's website |
999 |
_c27409821 _d27409821 |